載入...
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field of radiopharmaceutical development is rooted in t...
Na minha lista:
| 發表在: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465997/ https://ncbi.nlm.nih.gov/pubmed/32751666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13080173 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|